• Aucun résultat trouvé

allogeneic hematopoietic stem cell transplantation

Preemptive cellular immunotherapy after T-cell-depleted allogeneic hematopoietic stem cell transplantation.

Preemptive cellular immunotherapy after T-cell-depleted allogeneic hematopoietic stem cell transplantation.

... of allogeneic hematopoietic stem cell transplantation (allo-HSCT) ...and cell surface recognition molecules by host cells and thereby enhancing the recognition of host minor or ...

9

Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation (HSCT)

Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation (HSCT)

... Nonmyeloablative Transplantation. In: Soiffer RJ, editor. Hematopoietic Stem Cell ...given allogeneic hematopoietic cell transplanta- tion after nonmyeloablative ...to ...

7

Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT

Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT

... before transplantation. The emergence of hematopoietic complications after SOT requires specific treatment by hematologists, and a proportion of patients may be candidates for allogeneic ...

10

Allogeneic hematopoietic stem cell transplantation for T-prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM-TC)

Allogeneic hematopoietic stem cell transplantation for T-prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM-TC)

... that allogeneic hematopoietic stem cell transplantation (HSCT) might possibly serve to consolidate the response to initial ...for stem cell transplantation ...

5

Treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571.

Treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571.

... after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571 Donor lymphocyte infusion (DLI) has become standard therapy for relapse after ...

2

Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma

Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma

... Renal cell carcinoma (RCC) is particularly sensitive to immune ...after hematopoietic stem cell transplantation (HSCT), in particular the 14 bp insertion/deletion polymorphism in the 3 ...

6

The Impact of Donor Type on Long-Term Health Status and Quality of Life after Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Leukemia: A Leucemie de l'Enfant et de L'Adolescent Study

The Impact of Donor Type on Long-Term Health Status and Quality of Life after Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Leukemia: A Leucemie de l'Enfant et de L'Adolescent Study

... after Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Leukemia: A Leucemie de l’Enfant et de L’Adolescent Study Sandrine Visentin, Pascal Auquier, Yves Bertrand, ...

30

View of Non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation

View of Non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation

... · Allogeneic hematopoietic stem cell transplantation Introduction L ’allogreffe de cellules souches hématopoïétiques (ACSH) constitue un traitement curatif de différentes pathologies ...

8

Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Stud

Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study

... received transplantation in CR2, a Karnofsky performance score of 90, diagnosed with acute myeloid leukemia, received transplantation from a matched unrelated donor (MUD) in 2011, and both recipient and ...

10

Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning

Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning

... performing allogeneic hematopoietic stem cell transplantation (HSCT) in patients for whom conventional myeloablative allogeneic HSCT would have been associ- ated with ...

7

A prospective randomized multicenter trial of darbepoetin-alfa and I.V. iron administration after autologous hematopoietic stem cell transplantation.

A prospective randomized multicenter trial of darbepoetin-alfa and I.V. iron administration after autologous hematopoietic stem cell transplantation.

... P. Saussoy 1 , J. Libouton 1 , H. Antoine-Poirel 1 1 Cliniques Universitaires Saint-Luc, Brussels, 2 Centre Hospitalier de Luxembourg, Luxembourg A 19-year old woman was diagnosed with acute biphenotypic leukemia. ...

135

Use of chimerism analysis after allogeneic stem cell transplantation: Belgian guidelines and review of the current literature

Use of chimerism analysis after allogeneic stem cell transplantation: Belgian guidelines and review of the current literature

... Background: Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative treat- ment option in both adult and pediatric patients with malignant and non-malignant hemato- ...

10

Retrospective comparison of CD34-selected allogeneic peripheral blood stem cell transplantation followed by CD8-depleted donor lymphocyte infusions with unmanipulated bone marrow transplantation.

Retrospective comparison of CD34-selected allogeneic peripheral blood stem cell transplantation followed by CD8-depleted donor lymphocyte infusions with unmanipulated bone marrow transplantation.

... of allogeneic hematopoietic stem cell transplantation (HSCT) 1;2 ...donor stem cells that are primed by histocompatibility differences between donors and recipients and activated ...

21

Pre-emptive immunotherapy with CD8-depleted donor lymphocytes after CD34-selected allogeneic peripheral blood stem cell transplantation.

Pre-emptive immunotherapy with CD8-depleted donor lymphocytes after CD34-selected allogeneic peripheral blood stem cell transplantation.

... Recent evidence implicates a preparative regi- men-related cytokine storm in the pathogenesis of acute GVHD following hematopoietic stem cell transplantation. 44 Therefore, delaying the ...

11

Bacteremia after hematopoietic stem cell transplantation: incidence and predictive value of surveillance cultures.

Bacteremia after hematopoietic stem cell transplantation: incidence and predictive value of surveillance cultures.

... of stem cells (particularly true for autologous transplants since 1993 in our study) and a larger number of autologous transplants relative to the number of allogeneic ...

17

Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning

Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning

... after allogeneic hematopoietic cell transplantation (HCT) has remained unclear thus ...given allogeneic hemato- poietic stem cells after either nonmyeloablative (n ¼ 176) or ...

5

rhEPO in hematopoietic stem cell transplantation

rhEPO in hematopoietic stem cell transplantation

... A number of other factors may contribute to these differences. Epo levels inappropriately low for the degree of anemia are observed after amphotericin B administration (Lin et al. 1990), but this has not been a clear ...

32

Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia

Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia

... marrow transplantation [ 6 – 9 ...T cell dysfunction and promoting graft tolerance [ 14 ...and stem cell graft sources with GVHD and relapse incidence rates ...

12

Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin versus allogeneic bone marrow transplantation without anti-thymocyte globulin

Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin versus allogeneic bone marrow transplantation without anti-thymocyte globulin

... blood stem cells; AML: acute myeloid leukemia; ATG: anti-thymocyte globulin; HSCT: hematopoietic stem cell transplantation; IQR: interquartile range; CR: complete remission; CMV: ...

10

Comparison of Immune Reconstitution after Hematopoietic Stem Cell Transplantation with Flu-TBI versus TLI-ATG Conditioning

Comparison of Immune Reconstitution after Hematopoietic Stem Cell Transplantation with Flu-TBI versus TLI-ATG Conditioning

... P.68 Heterosexual HIV-1 Transmission is Associated with Allogeneic KIR/HLA Ligand Combinations Governing Natural Killer Cell Alloreactivity W. Jennes 1 , S. Verheyden 2 , C. Demanet 2 , J.W. Mertens 1 , C. ...

1

Show all 4512 documents...

Sujets connexes